About this trial
The aim of this clinical trial is to compare the benefit of early, systematic, multidisciplinary oncosexological care versus on-demand care on the sexual health of women with breast cancer.
Eligibility criteria
Qualifiers
Women ≥ 18 years (menopausal or not),
Localized breast cancer with or without lymph node involvement,
Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
Patient affiliated or benefiting from the social security system,
Disqualifiers
History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
Pregnant or breast-feeding women,
Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
Patients unable to comply with the study schedule for social, medical or psychological reasons.
Trial design
Treatments tested in this trial
- Early and systematic oncosexological supporting care